MAP2 and Alzheimer disease: Interestingly, while pTau immunoreactivity was found most abundantly in the outer regions of the retinal organoids (co-localized with NRL), we observed the largest increase in pTau expression between control and AD organoids in the inner regions of the organoids (co-localized with MAP2, Fig. 3x), suggesting that RGCs are primarily affected with these AD mutations.